AP
VIRX

Alydar Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Alydar Partners’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,169
Closed -$2.97M – 122
2014
Q2 		$2.97M Sell
2,169
-453
-17% -$620K 0.25% 57
2014
Q1 		$3.64M Buy
2,622
+48
+2% +$66.6K 0.36% 47
2013
Q4 		$2.56M Buy
2,574
+2,098
+441% +$2.09M 0.26% 62
2013
Q3 		$496K Buy
+476
New +$496K 0.04% 79